Ether Lipids Hyperactivate Dendritic Cells - Corner Therapeutics

Sun, 12 Apr 2026 05:30:49 +0000
Intellectual Property

The USPTO published patent application US20260097111A1 by Corner Therapeutics, Inc. on April 9, 2026, covering ether lipid (ETL) and ether phospholipid (ETPL) compounds for hyperactivating mammalian dendritic cells, including compositions combined with pathogen recognition receptor agonists, antigens, and dendritic cells. The application was originally filed on October 18, 2023.